| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Kremer J | |
| P2860 | cites work | Effect of cardiovascular comorbidities and concomitant aspirin use on selection of cyclooxygenase inhibitor among rheumatologists | Q28217480 |
| A gene-environment interaction between smoking and shared epitope genes in HLA-DR provides a high risk of seropositive rheumatoid arthritis | Q33982255 | ||
| Dietary risk factors for the development of inflammatory polyarthritis: evidence for a role of high level of red meat consumption | Q33983739 | ||
| Sensitivity to change of the health assessment questionnaire (HAQ) and other clinical and health status measures in rheumatoid arthritis: results of short-term clinical trials and observational studies versus long-term observational studies | Q67958014 | ||
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | iv37-41 | |
| P577 | publication date | 2005-11-01 | |
| P1433 | published in | Annals of the Rheumatic Diseases | Q4767876 |
| P1476 | title | The CORRONA database | |
| P478 | volume | 64 Suppl 4 |
| Q37100388 | A Prospective Evaluation of the Effects of Prevalent Depressive Symptoms on Disease Activity in Rheumatoid Arthritis Patients Treated With Biologic Response Modifiers |
| Q33760824 | A comparison of the malignancy incidence among patients with psoriatic arthritis and patients with rheumatoid arthritis in a large US cohort |
| Q33819684 | Association of methotrexate and tumour necrosis factor antagonists with risk of infectious outcomes including opportunistic infections in the CORRONA registry |
| Q45796102 | Chinese Registry of rheumatoid arthritis (CREDIT): II. prevalence and risk factors of major comorbidities in Chinese patients with rheumatoid arthritis |
| Q33608688 | Clinical and demographic factors associated with change and maintenance of disease severity in a large registry of patients with rheumatoid arthritis |
| Q37690878 | Clinical disease activity and acute phase reactant levels are discordant among patients with active rheumatoid arthritis: acute phase reactant levels contribute separately to predicting outcome at one year |
| Q37555886 | Commentary: the relative research unit: providing incentives for clinician participation in research activities |
| Q50155002 | Effect of treatment with biological agents for arthritis in Australia: the Australian Rheumatology Association Database |
| Q38543453 | Epidemiology research in rheumatology-progress and pitfalls. |
| Q37294493 | Evaluation of composite measures of treatment response without acute-phase reactants in patients with rheumatoid arthritis |
| Q36024297 | Greater likelihood of remission in rheumatoid arthritis patients treated earlier in the disease course: results from the Consortium of Rheumatology Researchers of North America registry |
| Q37672346 | Higher rates and clustering of abnormal lipids, obesity, and diabetes mellitus in psoriatic arthritis compared with rheumatoid arthritis |
| Q36836531 | Identifying factors associated with concordance with the American College of Rheumatology rheumatoid arthritis treatment recommendations. |
| Q47625115 | Impact of Sustained Remission on the Risk of Serious Infection in Patients With Rheumatoid Arthritis |
| Q38270662 | Improving the quality of care of patients with rheumatic disease using patient-centric electronic redesign software |
| Q34287960 | Malignancy validation in a United States registry of rheumatoid arthritis patients |
| Q34285092 | Predictors and persistence of new-onset clinical remission in rheumatoid arthritis patients. |
| Q35661221 | Prescribing practices in a US cohort of rheumatoid arthritis patients before and after publication of the American College of Rheumatology treatment recommendations |
| Q33551313 | Racial and ethnic disparities in disease activity in patients with rheumatoid arthritis |
| Q36524770 | Rare, low-frequency, and common variants in the protein-coding sequence of biological candidate genes from GWASs contribute to risk of rheumatoid arthritis |
| Q30891297 | Safety of biologics in rheumatoid arthritis: data from randomized controlled trials and registries |
| Q31123685 | Serious infection following anti-tumor necrosis factor alpha therapy in patients with rheumatoid arthritis: lessons from interpreting data from observational studies. |
| Q48226009 | Temporal associations between the different domains of rheumatoid arthritis disease activity and the onset of patient-reported depressive symptoms |
| Q36950687 | Temporal effect of depressive symptoms on the longitudinal evolution of rheumatoid arthritis disease activity |
| Q35048356 | The comparative effectiveness of abatacept versus anti-tumour necrosis factor switching for rheumatoid arthritis patients previously treated with an anti-tumour necrosis factor |
| Q35583230 | Thresholds in disease activity for switching biologics in rheumatoid arthritis patients: experience from a large U.S. cohort |
| Q36984088 | Tumor necrosis factor antagonist responsiveness in a United States rheumatoid arthritis cohort |
Search more.